Shortening the treatment of tuberculosis
- 1 February 2005
- journal article
- editorial
- Published by Springer Nature in Nature Biotechnology
- Vol. 23 (2) , 187-188
- https://doi.org/10.1038/nbt0205-187
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosisScience, 2005
- Predictive In Vitro Models of the Sterilizing Activity of Anti-Tuberculosis DrugsCurrent Pharmaceutical Design, 2004
- Moxifloxacin-containing Regimen Greatly Reduces Time to Culture Conversion in Murine TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Inhibition of Respiration by Nitric Oxide Induces aMycobacterium tuberculosisDormancy ProgramThe Journal of Experimental Medicine, 2003
- Emerging aspects of Buruli ulcer.Expert Review of Anti-infective Therapy, 2003
- Serial counts of Mycobacterium tuberculosis in sputum as surrogate markers of the sterilising activity of rifampicin and pyrazinamide in treating pulmonary tuberculosisBMC Pulmonary Medicine, 2001
- Modern methods for assessing the drugs used in the chemotherapy of mycobacterial diseaseJournal of Applied Microbiology, 1996
- Bioavailability of rifampin in experimental murine tuberculosisAntimicrobial Agents and Chemotherapy, 1992